These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18379176)

  • 1. Effect of different formulation variables on some particle characteristics of poly (DL-lactide-co-glycolide) nanoparticles.
    Mondal N; Samanta A; Pal TK; Ghosal SK
    Yakugaku Zasshi; 2008 Apr; 128(4):595-601. PubMed ID: 18379176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.
    Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
    Int J Pharm; 1999 Oct; 187(2):143-52. PubMed ID: 10502620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
    Rafiei P; Haddadi A
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
    Govender T; Stolnik S; Garnett MC; Illum L; Davis SS
    J Control Release; 1999 Feb; 57(2):171-85. PubMed ID: 9971898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the Conformation of Poly(L-lactide-co-glycolide) Molecules in Organic Solvents on Nanoparticle Size.
    Takeuchi I; Kimura Y; Makino K
    J Oleo Sci; 2020 Sep; 69(9):1125-1132. PubMed ID: 32788521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles.
    Mooguee M; Omidi Y; Davaran S
    J Pharm Sci; 2010 Aug; 99(8):3389-97. PubMed ID: 20229603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.
    Jeon HJ; Jeong YI; Jang MK; Park YH; Nah JW
    Int J Pharm; 2000 Oct; 207(1-2):99-108. PubMed ID: 11036235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
    Yeh MK; Davis SS; Coombes AG
    Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery.
    Errico C; Bartoli C; Chiellini F; Chiellini E
    J Biomed Biotechnol; 2009; 2009():571702. PubMed ID: 19789653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
    Sah AK; Suresh PK
    Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.
    Prabha S; Zhou WZ; Panyam J; Labhasetwar V
    Int J Pharm; 2002 Sep; 244(1-2):105-15. PubMed ID: 12204570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized formulation of high-payload PLGA nanoparticles containing insulin-lauryl sulfate complex.
    Shi K; Cui F; Yamamoto H; Kawashima Y
    Drug Dev Ind Pharm; 2009 Feb; 35(2):177-84. PubMed ID: 19016099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
    Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
    Mainardes RM; Evangelista RC
    Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
    Yang X; Patel S; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2014 Jun; 15(3):569-87. PubMed ID: 24504495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.